Qingdao Haier Biomedical Co (SHSE:688139) Marketable Securities: ¥554 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688139 Qingdao Haier Biomedical Co Ltd SHSE:688139
84 GF Score
Price ¥31.00
GF Value ¥37.15
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Qingdao Haier Biomedical Co Marketable Securities?

Qingdao Haier Biomedical Co SHSE:688139 -3.67% 84 Marketable Securities is ¥554 Mil as of Jun. 2026. GuruFocus rates SHSE:688139 with a GF Score™ of 84/100 and a GF Value™ of ¥37.15 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Qingdao Haier Biomedical Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥554 Mil.

Qingdao Haier Biomedical Co's annual Marketable Securities increased from Dec. 2023 (¥651 Mil) to Dec. 2024 (¥877 Mil) but then declined from Dec. 2024 (¥877 Mil) to Dec. 2025 (¥448 Mil).

Qingdao Haier Biomedical Co  (SHSE:688139) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Qingdao Haier Biomedical Co Marketable Securities Related Terms

Qingdao Haier Biomedical Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Qingdao Haier Biomedical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qingdao Haier Biomedical Co Marketable Securities Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,129.76 2,023.63 651.14 877.25 447.59

Qingdao Haier Biomedical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 792.04 653.41 447.59 505.41 553.59
SHSE:688139
84GF Score
Qingdao Haier Biomedical Co Ltd SHSE:688139
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qingdao Haier Biomedical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥554 Mil mean?
Qingdao Haier Biomedical Co (SHSE:688139) has a Marketable Securities of ¥554 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Qingdao Haier Biomedical Co and its competitors.
Is Qingdao Haier Biomedical Co's Marketable Securities too high?
Qingdao Haier Biomedical Co's current Marketable Securities is ¥554 Mil. Overall, Qingdao Haier Biomedical Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Haier Biomedical Co's Marketable Securities compare to ABT and SYK?
Qingdao Haier Biomedical Co's Marketable Securities of ¥554 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Qingdao Haier Biomedical Co and its competitors. Qingdao Haier Biomedical Co's current Marketable Securities is ¥554 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Haier Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Haier Biomedical Co (SHSE:688139) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥37.15, compared to a current price of ¥31.00 — trading 16.6% below its estimated fair value. The current Marketable Securities is ¥554 Mil. Qingdao Haier Biomedical Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Qingdao Haier Biomedical Co (SHSE:688139), the current Marketable Securities is ¥554 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qingdao Haier Biomedical Co (SHSE:688139) Overvalued in 2026?

Based on GuruFocus' analysis, Qingdao Haier Biomedical Co stock appears to be undervalued. The current stock price of ¥31.00 is trading 16.6% below its estimated GF Value™ of ¥37.15. GuruFocus considers Qingdao Haier Biomedical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688139:

  • Marketable Securities: ¥554 Mil
  • GF Value™: ¥37.15 vs. price of ¥31.00 (16.6% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688139 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qingdao Haier Biomedical Co Business Description

Address No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
84GF Score

Get the complete analysis for SHSE:688139

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.00
Price
¥37.15
GF Value